Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Robert P. Lisak
Sign up to set email alerts
685
Publications
9,402
Citation Statements Received
9,800
Citation Statements Given
How they've been cited
17,672
386
8,959
57
How they cite others
16,538
256
9,509
35
Affiliations
Wayne State University
,
University of Pennsylvania
Publications
Order By: Most citations
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson
1
,
Brooks
2
,
Cohen
3
et al.
1995
Neurology
Abstract
Show
1,903
21
1,059
5
Get access via publisher
Add to collection
Cite
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Howard
1
,
Utsugisawa
2
,
Benatar
3
et al.
2017
The Lancet Neurology
868
38
676
4
5
Get access via publisher
Add to collection
Cite
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
Howard
1
,
Bril
2
,
Vu
3
et al.
2021
The Lancet Neurology
750
45
553
3
3
Get access via publisher
Add to collection
Cite
Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture
RAFF
1
,
Mirsky
2
,
Fields
3
et al.
1978
Nature
827
3
338
1
Get access via publisher
Add to collection
Cite
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
Johnson
1
,
Brooks
2
,
Cohen
3
et al.
1998
Neurology
Abstract
Show
519
6
287
1
Get access via publisher
Add to collection
Cite
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
Howard
1
,
Bresch
2
,
Genge
3
et al.
2023
The Lancet Neurology
291
9
165
0
Get access via publisher
Add to collection
Cite
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis
Howard
1
,
Wolfe
2
,
Duda
3
et al.
2020
JAMA Neurol
Abstract
Show
211
3
164
1
Get access via publisher
Add to collection
Cite
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
Rae‐Grant
1
,
Day
2
,
Marrie
3
et al.
2018
Neurology
Abstract
Show
614
0
158
0
5
Get access via publisher
Add to collection
Cite
1
2
3
4